Spots Global Cancer Trial Database for Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
Official Title: Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
Study ID: NCT04455737
Conditions
Interventions
Study Description
Brief Summary: Background: An exact lymph node staging is essential in the treatment of rectal cancer. Objective: The aim of this study was to assess the effect of indigo carmine injection on the number of retrieved and positive lymph nodes after transanal total mesorectal excision (taTME). Design: This is a retrospective, non-randomised study. Settings: This study was conducted at a tertiary hospital by a multidisciplinary team. Patients: Between 2013 and 2019, patients undergoing transanal total mesorectal excision were analysed. Patients with indigo carmine injection (intervention group) were compared to those without (control group). Interventions: Transanal total mesorectal excision was performed with or without ex vivo intra-arterial indigo carmine injection. Main Outcome Measures: The number of retrieved and positive lymph nodes was the primary outcome measure.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of General, Visceral, Endocrine and Transplantation Surgery, Cantonal Hospital St. Gallen, Rorschach, , Switzerland
Contact Details
Name: Walter Brunner, MD MSc MBA
Affiliation: Kantonsspital St. Gallen, Rorschach branch, Department of Surgery
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
